January 26, 2026
“…Acumen Pharmaceuticals (ABOS)… With a major catalyst ahead and ABOS shares trading at $1.98, Stifel’s 5-star analyst Paul Matteis thinks now is the right time to make a move… To this end, Matteis rates ABOS a Buy, and his $10 price… Continue Reading…
December 5, 2025
“…Surf Air Mobility (SRFM), which trades at roughly $2 per share, is a rapidly evolving regional air mobility company. After seven consecutive quarters of meeting or exceeding guidance, and with an improved balance sheet and a high-potential AI software platform… Continue Reading…
May 21, 2024
“Sutro Biopharma (STRO)… “We think that luvelta has the potential to treat up to 80% of PROC patients, a significant improvement over the ~30% eligible for AbbVie’s Elahere (approved FolRα ADC)… Overall, the Strong Buy consensus rating on STRO is based… Continue Reading…
April 9, 2024
“…Ripple’s Brad Garlinghouse told CNBC he expects the entire value of the crypto market to double, citing macro factors including the arrival of the first U.S. spot bitcoin exchange-traded funds, as well as the upcoming so-called bitcoin “halving.”…” https://www.cnbc.com/2024/04/08/ripple-ceo-crypto-market-to-double-in-size-to-5-trillion-in-2024.html
March 15, 2024
“…Next up is the online insurance marketplace EverQuote. This company operates a platform that connects insurance buyers with insurance agents and covers multiple aspects of the industry… As more and more consumers, across the economy generally, turn to online and… Continue Reading…
January 12, 2024
“…Recent reports already show signs of strain. In the last year, credit card debt spiked to a record high, surpassing $1.08 trillion, according to the latest quarterly report from the Federal Reserve Bank of New York. Now, more cardholders are carrying debt from month to… Continue Reading…
January 14, 2021
“ContextLogic (WISH)… Wall Street is quite positive on this ‘Moderate Buy’ stock: WISH has received 8 ‘buy’ and 4 ‘hold’ ratings in the last three months. Running the numbers across the Street, the 12-month average price target lands at $26, representing… Continue Reading…
December 23, 2020
“Shell (ticker: RDS.B) stock is down 42% this year, worse than the Energy Select Sector SPD exchange-traded fund (XLE), which is off by 33%. But MKM Partners analyst John Gerdes says Shell shares could rebound by 68% as the company gets leaner… Continue Reading…
October 16, 2020
“Zynerba Pharmaceuticals (ZYNE)… Turning to the rest of the Street, the bulls have it on this one. With 3 Buys and a lone Hold, the word on the Street is that ZYNE is a Strong Buy. At $13, the average… Continue Reading…
October 9, 2020
“Mesa Air Group (MESA)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, MESA has a Strong Buy consensus rating. With the average price target… Continue Reading…
Recent Comments